EMA Withdrawn: Rotashield (rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant) — Wyeth Lederle Vaccines S.A.

View source ↗

Summary

Rotashield, a rotavirus vaccine, has been withdrawn from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rotashield

Snippet

Status: Withdrawn. Therapeutic area: Immunization;Rotavirus Infections. MAH: Wyeth Lederle Vaccines S.A.. Decision date: 31/12/2009